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Melioidosis was first recognized in northeastern Brazil
in 2003. Confirmation of additional cases from the 2003
cluster in Ceará, more recent cases in other districts, envi-
ronmental isolation of Burkholderia pseudomallei, molecu-
lar confirmation and typing results, and positive
serosurveillance specimens indicate that melioidosis is
more widespread in northeastern Brazil than previously
thought.
M
elioidosis is a fatal bacterial infection found in many
parts of the tropical belt, particularly in Southeast
Asia and northern Australia. Sporadic cases of the disease
have been reported previously in Central and South
America (1). In 2003 septicemic melioidosis was diag-
nosed for the first time in northeastern Brazil by culture of
the causal agent, Burkholderia pseudomallei from a 10-
year-old boy (2). That case is believed to be the first cul-
ture-confirmed case of melioidosis in Brazil and was part
of a small cluster of cases (hereafter termed Brazil out-
break l). At first, evidence that >1 case of melioidosis had
occurred was circumstantial. The diagnosis relied entirely
on the phenotypic features of a blood culture isolate from
the 10-year-old boy. A more detailed, multidisciplinary
investigation obtained further evidence for the case cluster
and clarified its likely relationship to infection in the sur-
rounding population. 
The Study 
Outbreak l comprised 4 previously healthy children
from the Municipality of Tejussuoca; the children were
admitted to the hospital with clinical features of systemic
infection over the course of 10 days (February 28–March
7, 2003) (Table 1; online Appendix Figure, available from
http://www.cdc.gov/ncidod/EID/vol11no09/05-0493_
app.htm). Three of the children died because of multiple
organ systems failure. Patient l died shortly after admis-
sion to a local hospital, before any diagnostic microbiolo-
gy tests could be arranged. Gram-negative bacilli were
isolated by blood culture from 2 children, patient 2 and
patient 3. For patient 2, the isolate did not survive prelim-
inary laboratory analysis, but findings at autopsy were
consistent with melioidosis (3). In patient 3, the isolate was
presumptively identified as B. pseudomallei. Bacterial
identification and susceptibility results came too late to
guide the treatment of patient 3, who also died, but did lead
to changes in antimicrobial drug therapy of patient 4, who
was admitted to the hospital later than the other 3 patients,
survived, and remains healthy. In her case, melioidosis was
demonstrated by laboratory evidence of late seroconver-
sion, detected by indirect hemagglutination assay.
Preliminary epidemiologic investigations indicated that
the children were probably infected when diving into an
irrigation reservoir that filled shortly after the onset of the
summer rains. 
Environmental studies conducted shortly after the case
cluster occurred (and then repeated with improved meth-
ods at a later date) did not isolate B. pseudomallei from this
location or other nearby sites. Adetailed review of surveil-
lance methods was undertaken, and external advice was
sought shortly before the ensuing rainy season. The pre-
sumptive B. pseudomallei isolate from patient 3 was sent
to a reference laboratory for independent confirmation and
molecular typing. A case definition was established for
prospective epidemiologic surveillance, and seroepidemi-
ologic studies began. External advice was sought for envi-
ronmental isolation methods.
The first clinical isolate (outbreak 1, patient 3, the 10-
year-old boy) was confirmed as B. pseudomallei by pheno-
typic and molecular methods, according to a validated
discovery pathway (4). In brief, polymerase chain reaction
(PCR)–based identification, gas-liquid chromatography of
fatty acid methyl esters, and an agglutinating monoclonal
antibody were used to confirm the isolate presumptively
identified as B. pseudomallei. 
Just over 1 year later, in 2004, several suspected cases
of septicemic melioidosis occurred in another location in
the State of Ceará (outbreak 2). The B. pseudomallei iso-
late from 1 such patient and 2 B. pseudomallei isolates
from soil and water samples in the corresponding environ-
mental study were sent for confirmation and molecular
typing, as before. The patient was from the Municipality of
Banabuiú, ≈400 km from the location of outbreak l. She
used to wash clothing while sitting in a nearby river. She
first complained of a perineal abscess, which persisted for
2 weeks before she was admitted to the hospital with sep-
ticemia.  B. pseudomallei was isolated by blood culture
after she died. The B. pseudomallei environmental isolates
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EcoR1 ribotyping showed that the B. pseudomallei iso-
late from patient 3 in the 2003 outbreak 1 was similar to
the Western Australian outbreak strain (Table 2, online
Appendix Figure). EcoR1 ribotyping discriminated
between 3 of the 4 Brazil B. pseudomallei isolates (Brazil
outbreak 1, patient 3: ribotype 1; unrelated later case in
second district: ribotype 6; and 2 environmental isolates
from second district: ribotypes 1 and 4). However, ribotyp-
ing was not as discriminating as DNA macrorestriction
typing (pulsed-field gel electrophoresis, PFGE), which
showed that the Brazil and Western Australian outbreak
isolates were distinct strains (Brazil outbreak, patient 3:
PFGE type 2, Western Australian outbreak strain: PFGE
type 1). 
Autopsy results from patient 2 in the original case clus-
ter were similar to those of the culture-positive third case-
patient and were consistent with melioidosis (3). The 1
survivor of the case cluster (Brazil outbreak 1, patient 4)
seroconverted (titer = 1:160) from an undetectable indirect
hemagglutination assay (IHA) titer around the time of her
infection. One parent was borderline positive by IHA(titer
of 1:40), and one was negative by IHA (<10). 
Of the 36 persons from both districts tested by IHA for
serologic evidence of exposure to B. pseudomallei, 14 had
titers >1:40; 7 had a titer of >1:160; and 2 had titers of
1:5,120. No significant associations occurred between
seropositivity and district, or seropositivity and age.
However, seropositivity and sex were significantly associ-
ated (Fisher exact test, p = 0.0159, relative risk = 0.320,
95% confidence interval [CI] = 0.12–0.83); 10 of 16
female patients had titers >40, the threshold titer, com-
pared to 4 of 20 male patients. This apparent association
between female sex and seropositivity is the reverse of the
association expected from experience in Southeast Asia.
Conclusions
At the time of writing, sporadic human infection has
been reported sporadically from other locations in north-
eastern Brazil, consistent with an emerging infectious dis-
ease. Prospective case surveillance, improved laboratory
diagnosis, and targeted environmental bacteriologic testing
will help clarify the epidemiology of melioidosis in this
region. Why this disease has appeared in Brazil remains
obscure, although our preliminary molecular typing results
indicate a possible link with Australian and Southeast
Asian infections through a putative common progenitor
strain. Veterinary investigation may help identify a possi-
ble means of introduction of the disease, since the goats
that feature in subsistence farming in Ceará may have been
imported from parts of the Caribbean where caprine
melioidosis is known to occur (5). An alternative hypothe-
sis is that B. pseudomallei was introduced through rice cul-
tivation. An environmental search for B. pseudomallei
(then Pseudomonas pseudomallei) was conducted shortly
after melioidosis was first reported in South and Central
America (6): a large number of water samples from rice
fields near São Paulo were cultured. No P. pseudomallei
was found, which led to the conclusion that the tempera-
ture and moisture of the environment did not favor the
microorganism. More recently, B. pseudomallei has been
presumptively identified in the root soil of sugar cane in
Melioidosis, Northeastern Brazil
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 9, September 2005 1459the São Paulo region (7). Rice is grown in parts of Ceará
where melioidosis cases have been identified and is an
important crop in other parts of the country. Further epi-
demiologic and environmental studies are needed to deter-
mine the extent of the environmental hazard and the risk it
represents for the human population and their livestock in
northern Brazil. Finally, the terrain in Ceará has many sim-
ilarities to northern Australia, where the summer rains are
known to coincide with most septicemic melioidosis cases
(8). In some parts of the Caribbean, sporadic melioidosis
cases appear to be a harbinger of more common disease
when flooding or other climatic determinants prevail
(9,10). The surveillance methods recently introduced in
Ceará may therefore help predict future melioidosis
events. Data on melioidosis serology results in an epidem-
ic setting are limited. The seroepidemiology survey con-
ducted after the Western Australian melioidosis outbreak
relied on access to previous serum samples from the same
community, fortuitously collected for other purposes
before the outbreak (11). Results from a serologic survey
based on single samples from each study participant, as in
Ceará, will necessarily have much wider CI. The investi-
gation into the Western Australian outbreak identified per-
sons who seroconverted without clinical evidence of B.
pseudomallei  infection. Carefully planned prospective
seroepidemiologic studies in northeastern Brazil will clar-
ify the importance of these preliminary observations.
Establishing the true prevalence of melioidosis in north-
eastern Brazil will help ascertain the threshold for serodi-
agnosis and the clinical relevance of borderline results. 
In the absence of any obvious anthropogenic changes
known to increase melioidosis risk, the unusual weather
systems operating in early 2003 appear to be the most like-
ly explanation for the apparent temporal and positional
clustering of cases. The diversity of molecular types of B.
pseudomallei and the seroprevalence of B. pseudomallei
antibody–positive persons are more consistent with an
endemic disease that has gone undetected for several years
than a recent, point-source incursion. Further epidemiolog-
ic studies will need to address whether the apparent emer-
gence of melioidosis in northeastern Brazil is due
primarily to improved ascertainment, the regional impact
of climate change, changes in land use, or a combination
of these factors.
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